Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration
Added on Sunday, January 01, 2006
Status changed on Monday, January 01, 2007 to: No maintenance for this code
